A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population

Breast Cancer Research and Treatment

Volumn 126, Issue 2, 2011, Pages 487-495

  Jiang, Lan ^a   Zhang, Chun ^b   Li, Yinyan ^c   Yu, Xiao ^a   Zheng, Jian ^a   Zou, Ping ^a   Li, Yuting ^a   Bin, Xiaonong ^c   Lu, Jiachun ^c   Zhou, Yifeng ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; EpCAM; Molecular epidemiology; Polymorphisms

Indexed keywords

ADENINE; CYTOSINE; EPITHELIAL CELL ADHESION MOLECULE; GUANINE; METHIONINE; THREONINE; THYMINE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CHINESE; CONTROLLED STUDY; EPITHELIAL CELL ADHESION MOLECULE GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; THR115MET GENE;

ADULT; AGE OF ONSET; ANTIGENS, NEOPLASM; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION MOLECULES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 79958742955     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1094-6     Document Type: Article

References (41)

1. Feig SA, Hendrick RE (1997) Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr 22:119-124
2. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the women's intervention nutrition study. J Natl Cancer Inst 98(24):1767-1776. doi:98/24/1767[pii]10.1093/jnci/djj494 (Pubitemid 46017928)
3. Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J (2006) The burden of cancer attributable to alcohol drinking. Int J Cancer 119(4):884-887. doi:10.1002/ijc.21903 (Pubitemid 44051453)
4. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354(3):270-282. doi:354/3/270[pii]10.10 56/NEJMra050776
5. Andrieu N, Clavel F, Auquier A, Le MG, Gairard B, Piana L, Bremond A, Lansac J, Flamant R, Renaud R (1993) Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol 46(9):973-980. doi:0895-4356(93)90164- V[pii] (Pubitemid 23258895)
6. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111. doi:10.1038/ 3510216735102167[pii] (Pubitemid 33041634)
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988. doi: 10.1073/pnas.05302911000530291100[pii] (Pubitemid 36418143)
8. Clarke MF (2005) A self-renewal assay for cancer stem cells. Cancer Chemother Pharmacol 1(56):64-68. doi: 10.1007/s00280-005-0097-1 (Pubitemid 41755693)
9. Soltysova A, Altanerova V, Altaner C (2005) Cancer stem cells. Neoplasma 52(6):435-440 (Pubitemid 41809399)
10. Ratajczak MZ (2005) Cancer stem cells-normal stem cells "jedi" that went over to the "dark side". Folia Histochem Cytobiol 43(4):175-181 (Pubitemid 41582134)
11. Sales KM, Winslet MC, Seifalian AM (2007) Stem cells and cancer: an overview. Stem Cell Rev 3(4):249-255. doi:10.1007/s12015-007-9002-0 (Pubitemid 351526201)
12. Luo J, Yin X, Ma T, Lu J (2010) Stem cells in normal mammary gland and breast cancer. Am J Med Sci 339(4):366-370. doi: 10.1097/MAJ.0b013e3181cad964
13. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M (2008) Cd44 and epcam: cancer-initiating cell markers. Curr Mol Med 8(8):784-804
14. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110. doi: nature 05372[pii]10.1038/nature05372 (Pubitemid 46067310)
15. Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO (1994) Evidence for a role of the epithelial glycoprotein 40 (ep-cam) in epithelial cell-cell adhesion. Cell Adhes Commun 2(5):417-428 (Pubitemid 24351019)
16. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC (2007) Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 171(2):386-395. doi: ajpath.2007.070152[pii]10.2353/ajpath.2007.070152 (Pubitemid 47344671)
17. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE (2004) Epcam is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64(16):5818-5824. doi:10.1158/0008-5472CAN-04-075464/16/5818[pii] (Pubitemid 39095582)
18. Balzar M, Winter MJ, de Boer CJ, Litvinov SV (1999) The biology of the 17-1a antigen (ep-cam). J Mol Med 77(10): 699-712
19. Aubele M, Werner M (1999) Heterogeneity in breast cancer and the problem of relevance of findings. Anal Cell Pathol 19(2): 53-58 (Pubitemid 30115048)
20. Golub TR (2001) Genome-wide views of cancer. N Engl J Med 344(8):601-602 (Pubitemid 32167875)
21. Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q (2007) 172 g >t variant in the 5' untranslated region of DNA repair gene rad51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a p53 codon 72 variant. Carcinogenesis 28(5):988-994. doi: bgl225[pii]10.1093/carcin/bgl225 (Pubitemid 47072182)
22. Lu J, Wei Q, Bondy ML, Yu TK, Li D, Brewster A, Shete S, Sahin A, Meric-Bernstam F, Wang LE (2006) Promoter polymorphism (-786t > c) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-hispanic white women age younger than 55 years. Cancer 107(9):2245-2253. doi:10.1002/cncr.22269 (Pubitemid 44665660)
23. Munz M, Baeuerle PA, Gires O (2009) The emerging role of epcam in cancer and stem cell signaling. Cancer Res 69(14): 5627-5629. doi:0008-5472.CAN-09- 0654[pii]10.1158/0008-54 72.CAN-09-0654
24. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O (2009) Nuclear signalling by tumour-associated antigen epcam. Nat Cell Biol 11(2):162-171. doi: ncb1824[pii]10.1038/ncb1824
25. Huelsken J, Behrens J (2002) The wnt signalling pathway. J Cell Sci 115(Pt 21):3977-3978 (Pubitemid 35446796)
26. Korswagen HC, Herman MA, Clevers HC (2000) Distinct beta-catenins mediate adhesion and signalling functions in C. elegans. Nature 406(6795):527-532. doi:10.1038/35020099 (Pubitemid 30625738)
27. Jaenisch R, Young R (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132(4):567-582. doi: S0092-8674(08)00115-3[pii]10.1016/j.cell.2008.01.015 (Pubitemid 351253686)
28. Chong JM, Speicher DW (2001) Determination of disulfide bond assignments and n-glycosylation sites of the human gastrointestinal carcinoma antigen ga733-2 (co17-1a, egp, ks1-4, ksa, and ep-cam). J Biol Chem 276(8):5804-5813. doi:10.1074/jbc.M0088 39200M008839200[pii]
29. Braun S, Pantel K (1998) Prognostic significance of micrometa-static bone marrow involvement. Breast Cancer Res Treat 52(1-3):201-216 (Pubitemid 29056096)
30. Trebak M, Begg GE, Chong JM, Kanazireva EV, Herlyn D, Speicher DW (2001) Oligomeric state of the colon carcinoma-associated glycoprotein ga733-2 (ep-cam/egp40) and its role in ga733-mediated homotypic cell-cell adhesion. J Biol Chem 276(3):2299-2309. doi:10.1074/jbc.M004770200M004770200 [pii] (Pubitemid 32109716)
31. Baeuerle PA, Gires O (2007) Epcam (cd326) finding its role in cancer. Br J Cancer 96(3):417-423. doi:6603494[pii]10.1038/sj. bjc.6603494 (Pubitemid 46215211)
32. Armstrong A, Eck SL (2003) Epcam: a new therapeutic target for an old cancer antigen. Cancer Biol Ther 2(4):320-326. doi: 451[pii]
33. Moll J, Sleeman J, Kondo K, Hekele A, Plug R, Sherman L, Ponta H, Herrlich P, Schmidt A, Zoller M et al (1994) Analysis of molecular functions of the tumor metastasis promoting surface molecule cd44v4-v7 using transgenic mice. Princess Takamatsu Symp 24:142-151
34. Schmidt DS, Klingbeil P, Schnolzer M, Zoller M (2004) Cd44 variant isoforms associate with tetraspanins and epcam. Exp Cell Res 297(2):329-347. doi:10.1016/j.yexcr.2004.02.023, S00 1448 2704001090 [pii] (Pubitemid 38798397)
35. Wurfel J, Rosel M, Seiter S, Claas C, Herlevsen M, Weth R, Zoller M (1999) Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen egp314. Oncogene 18(14): 2323-2334. doi:10.1038/sj.onc. 1202542 (Pubitemid 29192709)
36. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434-442 (Pubitemid 38443646)
37. Momburg F, Moldenhauer G, Hammerling GJ, Moller P (1987) Immunohistochemical study of the expression of a mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47(11):2883-2891 (Pubitemid 17113431)
38. Bergsagel PL, Victor-Kobrin C, Brents LA, Mushinski JF, Kuehl WM (1992) Genes expressed selectively in plasmacytomas: markers of differentiation and transformation. Curr Top Microbiol Immunol 182:223-228 (Pubitemid 23018885)
39. Gastl G, Spizzo G, Obrist P, Dunser M, Mikuz G (2000) Ep-cam overexpression in breast cancer as a predictor of survival. Lancet 356(9246):1981-1982. doi: S0140-6736(00)03312-2[pii]10.1016/S0140-6736(00)03312- 2
40. Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ, Warnaar SO (1996) Expression of ep-cam in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148(3):865-875 (Pubitemid 126660678)
41. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S (2004) Frequent epcam protein expression in human carcinomas. Hum Pathol 35(1):122-128. doi: S004681770300502 1[pii] (Pubitemid 38133932)